Global WholeHealth Partners Corp (GWHP-OTC) to Announce an Antibody “Confident” Test Which Can Detect the S1 RDT Antigen Used in COVID 19 Vaccines

Press Release

People are looking to be confident in the vaccine working. After all the news of vaccines not working as well as we had hoped, people want to know, did the vaccine I received work?  Global’s Antibody “Confident Test” can detect the S1 RDT Antigen in Vaccines. The test is sensitive enough to be able to detect the S1 RDT Antigen in Blood, Saliva, and Urine.  Once a person gets the vaccine, the person can be tested to see if the vaccine took effect.San Clemente, CA – (NewMediaWire) – March 03, 2021 – Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest line of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses.  The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer the virus.“This is a wartime undertaking,” President Biden said. “Today, I’m signing executive action to use the Defense Production Act and all other available authorities to direct all federal agencies and private entities to accelerate the making of everything that’s needed to protect, test, vaccinate, and take care of our people.” https://philadelphia.cbslocal.com/2021/01/21/president-joe-biden-country-at-war-coronavirus/Under Mr. Strongo’s direction, Global is following the President and his leadership and is making a war on COVID. To conquer COVID and win this war, Global must keep up the research and development of tests.Charles Strongo, CEO of Global WholeHealth Partners Corp (OTC:GWHP), comments on https://www.cbsnews.com/news/covid-death-toll-united-states-expected-500k-february/ regarding the potential of 500,000 deaths by mid-February, as stated by the incoming director of the Centers for Disease Control. Mr. Strongo states that “the statement about the death toll reaching 500,000 is staggering, and it is our responsibility to be tested and to follow the rules of the CDC. We must keep testing, wearing masks and following the rules of social distancing, as directed by the CDC.  We can defeat this virus. We must not take it lightly. It has killed thousands.”The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows detecting the virus quickly, is growing. The adoption of a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for Covid-19 diagnostics kits. The shift from symptomatic testing to mass testing in developed countries is another major factor affecting the market.Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.With results in minutes versus hours or days with other diagnostic kits, the more lives that can be saved with the only FDA authorized COVID-19 POC serology Point of Care Test. With the new fingerstick test, healthcare providers can prick a patient’s finger and get results in minutes without having to wait for venous blood. Global WholeHealth Partners will be able to distribute these tests to more urgent cares, hospitals, and – to help curb the spread of CoViD19 SARS2.As a third surge of the coronavirus threatens much of the United States, public health experts across the country say there still aren’t enough tests available to keep the virus under control.About 30 million Covid-19 tests are given every month, according to estimates from The Atlantic magazine’s Covid Tracking Project. But studies have found that the U.S. would need millions more — …